Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

A magnetic resonance multi-atlas for the neonatal rabbit brain.

Ferraris S, van der Merwe J, Van Der Veeken L, Prados F, Iglesias JE, Melbourne A, Lorenzi M, Modat M, Gsell W, Deprest J, Vercauteren T.

Neuroimage. 2018 Oct 1;179:187-198. doi: 10.1016/j.neuroimage.2018.06.029. Epub 2018 Jun 14.

2.

Effects of alcohol exposure on the glutamatergic system: a combined longitudinal 18 F-FPEB and 1 H-MRS study in rats.

de Laat B, Weerasekera A, Leurquin-Sterk G, Gsell W, Bormans G, Himmelreich U, Casteels C, Van Laere K.

Addict Biol. 2018 May 23. doi: 10.1111/adb.12635. [Epub ahead of print]

PMID:
29790622
3.

The human somatostatin receptor type 2 as an imaging and suicide reporter gene for pluripotent stem cell-derived therapy of myocardial infarction.

Neyrinck K, Breuls N, Holvoet B, Oosterlinck W, Wolfs E, Vanbilloen H, Gheysens O, Duelen R, Gsell W, Lambrichts I, Himmelreich U, Verfaillie CM, Sampaolesi M, Deroose CM.

Theranostics. 2018 Apr 14;8(10):2799-2813. doi: 10.7150/thno.22980. eCollection 2018.

4.

Assessing cell-nanoparticle interactions by high content imaging of biocompatible iron oxide nanoparticles as potential contrast agents for magnetic resonance imaging.

Hachani R, Birchall MA, Lowdell MW, Kasparis G, Tung LD, Manshian BB, Soenen SJ, Gsell W, Himmelreich U, Gharagouzloo CA, Sridhar S, Thanh NTK.

Sci Rep. 2017 Aug 10;7(1):7850. doi: 10.1038/s41598-017-08092-w.

5.

Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate.

Schrantee A, Tremoleda JL, Wylezinska-Arridge M, Bouet V, Hesseling P, Meerhoff GF, de Bruin KM, Koeleman J, Freret T, Boulouard M, Desfosses E, Galineau L, Gozzi A, Dauphin F, Gsell W, Booij J, Lucassen PJ, Reneman L.

PLoS One. 2017 Feb 27;12(2):e0172776. doi: 10.1371/journal.pone.0172776. eCollection 2017.

6.

Influence of shear stress magnitude and direction on atherosclerotic plaque composition.

Pedrigi RM, Mehta VV, Bovens SM, Mohri Z, Poulsen CB, Gsell W, Tremoleda JL, Towhidi L, de Silva R, Petretto E, Krams R.

R Soc Open Sci. 2016 Oct 19;3(10):160588. eCollection 2016 Oct.

7.

Quantitative MRI biomarkers to characterize regional left ventricular perfusion and function in nonhuman primates during dobutamine-induced stress: A reproducibility and reliability study.

Sampath S, Parimal AS, Feng D, Chang MM, Baumgartner R, Klimas M, Jacobsen K, Manigbas E, Gsell W, Evelhoch JL, Chin CL.

J Magn Reson Imaging. 2017 Feb;45(2):556-569. doi: 10.1002/jmri.25379. Epub 2016 Jul 7.

PMID:
27384520
8.

Heart rate reduction with ivabradine promotes shear stress-dependent anti-inflammatory mechanisms in arteries.

Luong L, Duckles H, Schenkel T, Mahmoud M, Tremoleda JL, Wylezinska-Arridge M, Ali M, Bowden NP, Villa-Uriol MC, van der Heiden K, Xing R, Gijsen FJ, Wentzel J, Lawrie A, Feng S, Arnold N, Gsell W, Lungu A, Hose R, Spencer T, Halliday I, Ridger V, Evans PC.

Thromb Haemost. 2016 Jul 4;116(1):181-90. doi: 10.1160/TH16-03-0214. Epub 2016 Apr 14.

PMID:
27075869
9.

PET imaging of TSPO in a rat model of local neuroinflammation induced by intracerebral injection of lipopolysaccharide.

Ory D, Planas A, Dresselaers T, Gsell W, Postnov A, Celen S, Casteels C, Himmelreich U, Debyser Z, Van Laere K, Verbruggen A, Bormans G.

Nucl Med Biol. 2015 Oct;42(10):753-61. doi: 10.1016/j.nucmedbio.2015.06.010. Epub 2015 Jun 23.

PMID:
26220690
10.

Dopaminergic system dysfunction in recreational dexamphetamine users.

Schrantee A, Václavů L, Heijtel DF, Caan MW, Gsell W, Lucassen PJ, Nederveen AJ, Booij J, Reneman L.

Neuropsychopharmacology. 2015 Mar 13;40(5):1172-80. doi: 10.1038/npp.2014.301.

11.

In vivo mapping of vascular inflammation using the translocator protein tracer 18F-FEDAA1106.

Cuhlmann S, Gsell W, Van der Heiden K, Habib J, Tremoleda JL, Khalil M, Turkheimer F, Meens MJ, Kwak BR, Bird J, Davenport AP, Clark J, Haskard D, Krams R, Jones H, Evans PC.

Mol Imaging. 2014;13. doi: 10.2310/7290.2014.00014.

PMID:
24825602
12.

T₁ mapping detects pharmacological retardation of diffuse cardiac fibrosis in mouse pressure-overload hypertrophy.

Stuckey DJ, McSweeney SJ, Thin MZ, Habib J, Price AN, Fiedler LR, Gsell W, Prasad SK, Schneider MD.

Circ Cardiovasc Imaging. 2014 Mar;7(2):240-9. doi: 10.1161/CIRCIMAGING.113.000993. Epub 2014 Jan 14.

13.

Aldehyde dehydrogenase 2 in sporadic Parkinson's disease.

Michel TM, Käsbauer L, Gsell W, Jecel J, Sheldrick AJ, Cortese M, Nickl-Jockschat T, Grünblatt E, Riederer P.

Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S68-72. doi: 10.1016/S1353-8020(13)70018-X.

PMID:
24262192
14.

Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments.

Zhao L, Ashek A, Wang L, Fang W, Dabral S, Dubois O, Cupitt J, Pullamsetti SS, Cotroneo E, Jones H, Tomasi G, Nguyen QD, Aboagye EO, El-Bahrawy MA, Barnes G, Howard LS, Gibbs JS, Gsell W, He JG, Wilkins MR.

Circulation. 2013 Sep 10;128(11):1214-24. doi: 10.1161/CIRCULATIONAHA.113.004136. Epub 2013 Jul 30.

15.
16.

Haemodynamics in the mouse aortic arch computed from MRI-derived velocities at the aortic root.

Van Doormaal MA, Kazakidi A, Wylezinska M, Hunt A, Tremoleda JL, Protti A, Bohraus Y, Gsell W, Weinberg PD, Ethier CR.

J R Soc Interface. 2012 Nov 7;9(76):2834-44. Epub 2012 Jul 4.

17.

Increased energy expenditure in gastric bypass rats is not caused by activated brown adipose tissue.

Hankir M, Bueter M, Gsell W, Seyfried F, Khalil M, Smith KL, Bloom SR, Bell JD, le Roux CW.

Obes Facts. 2012;5(3):349-58. doi: 10.1159/000339742. Epub 2012 Jun 12.

18.

The use of pharmacological-challenge fMRI in pre-clinical research: application to the 5-HT system.

Klomp A, Tremoleda JL, Schrantee A, Gsell W, Reneman L.

J Vis Exp. 2012 Apr 25;(62). pii: 3956. doi: 10.3791/3956.

19.

Roux-en-Y gastric bypass in mice--surgical technique and characterisation.

Seyfried F, Lannoo M, Gsell W, Tremoleda JL, Bueter M, Olbers T, Jurowich C, Germer CT, le Roux CW.

Obes Surg. 2012 Jul;22(7):1117-25. doi: 10.1007/s11695-012-0661-9.

PMID:
22527601
20.

Imaging technologies for preclinical models of bone and joint disorders.

Tremoleda JL, Khalil M, Gompels LL, Wylezinska-Arridge M, Vincent T, Gsell W.

EJNMMI Res. 2011 Jul 29;1(1):11. doi: 10.1186/2191-219X-1-11.

21.

Age-dependent effects of chronic fluoxetine treatment on the serotonergic system one week following treatment.

Bouet V, Klomp A, Freret T, Wylezinska-Arridge M, Lopez-Tremoleda J, Dauphin F, Boulouard M, Booij J, Gsell W, Reneman L.

Psychopharmacology (Berl). 2012 May;221(2):329-39. doi: 10.1007/s00213-011-2580-1. Epub 2011 Dec 24.

PMID:
22205158
22.

Lasting effects of chronic fluoxetine treatment on the late developing rat brain: age-dependent changes in the serotonergic neurotransmitter system assessed by pharmacological MRI.

Klomp A, Tremoleda JL, Wylezinska M, Nederveen AJ, Feenstra M, Gsell W, Reneman L.

Neuroimage. 2012 Jan 2;59(1):218-26. doi: 10.1016/j.neuroimage.2011.07.082. Epub 2011 Aug 4.

PMID:
21840402
23.

Molecular SPECT Imaging: An Overview.

Khalil MM, Tremoleda JL, Bayomy TB, Gsell W.

Int J Mol Imaging. 2011;2011:796025. doi: 10.1155/2011/796025. Epub 2011 Apr 5.

24.

Disturbed blood flow induces RelA expression via c-Jun N-terminal kinase 1: a novel mode of NF-κB regulation that promotes arterial inflammation.

Cuhlmann S, Van der Heiden K, Saliba D, Tremoleda JL, Khalil M, Zakkar M, Chaudhury H, Luong le A, Mason JC, Udalova I, Gsell W, Jones H, Haskard DO, Krams R, Evans PC.

Circ Res. 2011 Apr 15;108(8):950-9. doi: 10.1161/CIRCRESAHA.110.233841. Epub 2011 Feb 24.

25.

Can enzyme kinetics of prooxidants teach us a lesson about the treatment of Alzheimer's disease: a pilot post-mortem study.

Michel TM, Gsell W, Geuder J, Frangou S, Durany N, Kircher T, Sheldrick AJ, Tatschner T, Schneider F, Riederer P, Grünblatt E.

World J Biol Psychiatry. 2010 Jun;11(4):677-81. doi: 10.3109/15622971003728014.

PMID:
20380619
26.

Guanidino compound levels in blood, cerebrospinal fluid, and post-mortem brain material of patients with argininemia.

Deignan JL, De Deyn PP, Cederbaum SD, Fuchshuber A, Roth B, Gsell W, Marescau B.

Mol Genet Metab. 2010;100 Suppl 1:S31-6. doi: 10.1016/j.ymgme.2010.01.012. Epub 2010 Jan 29.

PMID:
20176499
27.

Increased activity of mitochondrial aldehyde dehydrogenase (ALDH) in the putamen of individuals with Alzheimer's disease: a human postmortem study.

Michel TM, Gsell W, Käsbauer L, Tatschner T, Sheldrick AJ, Neuner I, Schneider F, Grünblatt E, Riederer P.

J Alzheimers Dis. 2010;19(4):1295-301. doi: 10.3233/JAD-2010-1326.

28.

Differences in the evolution of the ischemic penumbra in stroke-prone spontaneously hypertensive and Wistar-Kyoto rats.

McCabe C, Gallagher L, Gsell W, Graham D, Dominiczak AF, Macrae IM.

Stroke. 2009 Dec;40(12):3864-8. doi: 10.1161/STROKEAHA.109.559021. Epub 2009 Sep 24.

29.

Potential use of oxygen as a metabolic biosensor in combination with T2*-weighted MRI to define the ischemic penumbra.

Santosh C, Brennan D, McCabe C, Macrae IM, Holmes WM, Graham DI, Gallagher L, Condon B, Hadley DM, Muir KW, Gsell W.

J Cereb Blood Flow Metab. 2008 Oct;28(10):1742-53. doi: 10.1038/jcbfm.2008.56. Epub 2008 Jun 11.

30.

Estrogen receptor beta agonist diarylpropiolnitrile (DPN) does not mediate neuroprotection in a rat model of permanent focal ischemia.

Farr TD, Carswell HV, Gsell W, Macrae IM.

Brain Res. 2007 Dec 14;1185:275-82. Epub 2007 Sep 16.

PMID:
17942083
32.

Differential effects of NMDA and AMPA glutamate receptors on functional magnetic resonance imaging signals and evoked neuronal activity during forepaw stimulation of the rat.

Gsell W, Burke M, Wiedermann D, Bonvento G, Silva AC, Dauphin F, Bührle C, Hoehn M, Schwindt W.

J Neurosci. 2006 Aug 16;26(33):8409-16.

33.

Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer's disease.

Völkel W, Sicilia T, Pähler A, Gsell W, Tatschner T, Jellinger K, Leblhuber F, Riederer P, Lutz WK, Götz ME.

Neurochem Int. 2006 Jun;48(8):679-86. Epub 2006 Feb 17.

PMID:
16483694
34.

Brain aging phenomena in migrating sockeye salmon Oncorhynchus nerka nerka.

Götz ME, Malz CR, Dirr A, Blum D, Gsell W, Schmidt S, Burger R, Pohli S, Riederer P.

J Neural Transm (Vienna). 2005 Sep;112(9):1177-99. Epub 2005 Jan 31.

PMID:
15682270
35.

Impairment of G(salpha) function in human brain cortex of Alzheimer's disease: comparison with normal aging.

Hashimoto E, Ozawa H, Saito T, Gsell W, Takahata N, Riederer P, Frölich L.

J Neural Transm (Vienna). 2004 Mar;111(3):311-22. Epub 2003 Dec 29.

PMID:
14991457
36.

(r)-, but not (s)-alpha lipoic acid stimulates deficient brain pyruvate dehydrogenase complex in vascular dementia, but not in Alzheimer dementia.

Frölich L, Götz ME, Weinmüller M, Youdim MB, Barth N, Dirr A, Gsell W, Jellinger K, Beckmann H, Riederer P.

J Neural Transm (Vienna). 2004 Mar;111(3):295-310. Epub 2003 Oct 24.

PMID:
14991456
37.

Functional neurochemistry of Alzheimer's disease.

Gsell W, Jungkunz G, Riederer P.

Curr Pharm Des. 2004;10(3):265-93. Review.

PMID:
14754387
38.

Chronic alcohol consumption and cerebral indices of oxidative stress: is there a link?

Götz ME, Janetzky B, Pohli S, Gottschalk A, Gsell W, Tatschner T, Ransmayr G, Leblhuber F, Gerlach M, Reichmann H, Riederer P, Böning J.

Alcohol Clin Exp Res. 2001 May;25(5):717-25.

PMID:
11371721
39.

Inhibition of neuronal nitric oxide synthase by 7-methoxyindazole and related substituted indazoles.

Schumann P, Collot V, Hommet Y, Gsell W, Dauphin F, Sopkova J, MacKenzie ET, Duval D, Boulouard M, Rault S.

Bioorg Med Chem Lett. 2001 May 7;11(9):1153-6.

PMID:
11354365
40.

Long-term effects of tricyclic antidepressants on norepinephrine kinetics in humans.

Jungkun G, Kuss HJ, Gsell W.

J Neural Transm (Vienna). 2001;108(3):349-62.

PMID:
11341486
41.

Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs.

Czub S, Koutsilieri E, Sopper S, Czub M, Stahl-Hennig C, Müller JG, Pedersen V, Gsell W, Heeney JL, Gerlach M, Gosztonyi G, Riederer P, ter Meulen V.

Acta Neuropathol. 2001 Feb;101(2):85-91.

PMID:
11271377
42.

The use of cerebral blood flow as an index of neuronal activity in functional neuroimaging: experimental and pathophysiological considerations.

Gsell W, De Sadeleer C, Marchalant Y, MacKenzie ET, Schumann P, Dauphin F.

J Chem Neuroanat. 2000 Dec;20(3-4):215-24. Review.

PMID:
11207420
43.

Pro- and antioxidative properties of cortical tissue preparations from human brain exhibiting NMDA-receptor characteristics.

Elstner M, Denke A, Gsell W, Elstner EF, Riederer P, Gerlach M.

Z Naturforsch C. 1999 May-Jun;54(5-6):438-45.

PMID:
10431395
44.

Acetylcholine in human CSF: methodological considerations and levels in dementia of Alzheimer type.

Frölich L, Dirr A, Götz ME, Gsell W, Reichmann H, Riederer P, Maurer K.

J Neural Transm (Vienna). 1998;105(8-9):961-73.

PMID:
9869329
45.

Free radicals in Alzheimer's disease.

Retz W, Gsell W, Münch G, Rösler M, Riederer P.

J Neural Transm Suppl. 1998;54:221-36. Review.

PMID:
9850931
47.

Platelet monoamine oxidase B activity in dementia. A 4-year follow-up.

Götz ME, Fischer P, Gsell W, Riederer P, Streifler M, Simanyi M, Müller F, Danielczyk W.

Dement Geriatr Cogn Disord. 1998 Mar-Apr;9(2):74-7.

PMID:
9524797
48.

Time course of manganese superoxide dismutase concentrations in serum of alcohol-dependent patients during abstinence.

Thome J, Nara K, Foley P, Gsell W, Wiesbeck GA, Böning J, Riederer P.

Drug Alcohol Depend. 1997 Mar 14;44(2-3):151-5.

PMID:
9088787
50.

Neurochemical abnormalities in Alzheimer's disease and Parkinson's disease--a comparative review.

Gsell W, Strein I, Krause U, Riederer P.

J Neural Transm Suppl. 1997;51:145-59.

PMID:
9470135

Supplemental Content

Support Center